Google Glass Technology Less Reliable Than Paper ECG

This article originally appeared here.
Share this content:
Google Glass Technology Less Reliable Than Paper ECG
Google Glass Technology Less Reliable Than Paper ECG

MONDAY, Jan. 19, 2015 (HealthDay News) -- Google Glass technology for remote electrocardiogram (ECG) interpretation is significantly less reliable than paper ECG, according to a study published in the Feb. 1 issue of The American Journal of Cardiology.

Omar M. Jeroudi, M.D., from the Veterans Affairs North Texas Health Care System in Dallas, and colleagues examined the accuracy of remote ECG interpretation using Google Glass, an optical head-mounted display device. Interpretations of 10 ECGs with 21 clinically important findings were compared by researchers. The researchers viewed the ECG image at the Google Glass screen, as a photograph of the ECG taken using Google Glass and displayed on a mobile device, as the original paper ECG, and as a high-resolution photograph of the original ECG displayed on a mobile device. Four faculty members and eight fellow cardiologists participated.

The researchers found that the average electrocardiographic interpretation score (one point for identification of each correct finding) was 13.5 ± 1.8 for Google Glass, 16.1 ± 2.6 for Google Glass photograph on a mobile device, 18.3 ± 1.7 for paper ECG, and 18.6 ± 1.5 for high-resolution picture of paper ECG on mobile device. Seventy-five percent of the physicians were dissatisfied with ECG viewing on the prism display of Google Glass.

"In conclusion, further improvements are needed before Google Glass can be reliably used for remote electrocardiographic analysis," the authors write.

Two authors disclosed financial ties to pharmaceutical and medical technology companies.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »